ConductScience.org, home

Paper2302723

Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.

Knisely TL and 1 other. Cancer Immunol Immunother, 1990. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye. Papers, record 2302723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2302723

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2024-04-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knisely TLT L
2Niederkorn JYJ Y

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anterior ChamberMajor topic
Cytotoxicity, ImmunologicMajor topic
Eye NeoplasmsMajor topic
T-Lymphocytes, CytotoxicMajor topic
Animals
Cell Separation
Female
Flow Cytometry
Graft Rejection
Histocompatibility Antigens Class II
Hypersensitivity, Delayed
Macrophages
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasm Transplantation
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA030276NCI NIH HHSUnited StatesR01CA030276PubMed and NIHNIH RePORTER
R37 CA030276NCI NIH HHSUnited StatesR01CA030276PubMed and NIHNIH RePORTER
EYO5631NEI NIH HHSUnited StatesPubMedPubMed
CA30276NCI NIH HHSUnited StatesR01CA030276PubMed and NIHNIH RePORTER
R37CA030276NIHNIH RePORTER

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11084897Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.J Immunol1976https://conductscience.org/library/papers/1084897PubMed
23875569Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells.Int J Cancer1985https://conductscience.org/library/papers/3875569PubMed
36403609Recombinant interferon-gamma increases HLA-DR synthesis and expression.J Immunol1983https://conductscience.org/library/papers/6403609PubMed
46980254Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.J Exp Med1982https://conductscience.org/library/papers/6980254PubMed
56195085
Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.
Immunol Rev1983https://conductscience.org/library/papers/6195085PubMed
63024832Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3024832PubMed
7301897Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.J Immunol1977https://conductscience.org/library/papers/301897PubMed
86996909Separation of individual kinds of cells from tumors.Contemp Top Immunobiol1980https://conductscience.org/library/papers/6996909PubMed
96776227Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.J Exp Med1980https://conductscience.org/library/papers/6776227PubMed
107009746Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.J Immunol1981https://conductscience.org/library/papers/7009746PubMed
113029221Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.J Immunol1987https://conductscience.org/library/papers/3029221PubMed
12300075Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo.Int J Cancer1977https://conductscience.org/library/papers/300075PubMed
1311515089Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.J Natl Cancer Inst1970https://conductscience.org/library/papers/11515089PubMed
146227669Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells.J Immunol1983https://conductscience.org/library/papers/6227669PubMed
152783319Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.J Immunol1989https://conductscience.org/library/papers/2783319PubMed
16316708Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.Br J Cancer1979https://conductscience.org/library/papers/316708PubMed
176282973Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature.J Immunol1982https://conductscience.org/library/papers/6282973PubMed
183108394Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.J Immunol1987https://conductscience.org/library/papers/3108394PubMed
193855286Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.Cancer Res1985https://conductscience.org/library/papers/3855286PubMed
203260908Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.J Immunol1988https://conductscience.org/library/papers/3260908PubMed

See all 60 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
33194647Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma.Front Oncol2020https://conductscience.org/library/papers/33194647PubMed
31750244Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets.Front Oncol2019https://conductscience.org/library/papers/31750244PubMed
22693246IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact.J Leukoc Biol2012https://conductscience.org/library/papers/22693246PubMed
21918192IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.J Immunol2011https://conductscience.org/library/papers/21918192PubMed
20482389Immune privilege of corneal allografts.Ocul Immunol Inflamm2010https://conductscience.org/library/papers/20482389PubMed
19563908Immune escape mechanisms of intraocular tumors.Prog Retin Eye Res2009https://conductscience.org/library/papers/19563908PubMed
17944931CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages.Immunology2008https://conductscience.org/library/papers/17944931PubMed
1937568In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber.Immunology1991https://conductscience.org/library/papers/1937568PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2302723

GET https://conductscience.org/api/papers/v1/2302723/references?page=2